Literature DB >> 24631754

Serum interleukin-6 levels in murine models of Candida albicans infection.

Renátó Kovács1, Anita Czudar1, László Horváth2, Levente Szakács1, László Majoros1, József Kónya1.   

Abstract

Two Balb/C mouse models of Candida infection were used to detect serum interleukin-6 (IL-6) responses. The first model used systemic infection by Candida albicans ATCC 10231 strain infected through the lateral tail vein of mice without any specific pretreatment. The median Candida burdens of the kidneys were 1.5 × 106 CFU/ml 24 h postinoculation (p.i.) and 1.2 × 107 CFU/ml 72 h p.i., while median serum IL-6 levels were 479.3 pg/ml and 934.5 pg/ml, respectively. The Candida burden showed significant correlation with serum IL-6 24 h p.i. (R2 = 0.6358; P = 0.0082) but not 72 h p.i.The second model was a mouse vaginitis model applying intravaginal inoculation of mice pretreated with subcutaneous estradiol-valerate (10 mg/ml) 3 days before infection. Candida cell count in vaginal lavage fluid was 2.8 × 106 CFU/ml 24 h p.i. and 1.4 × 108 CFU/ml 72 h p.i. Serum IL-6 response was detected in 4 of 15 mice 24 h p.i. and 9 of 15 mice 72 h p.i. Even the responders had low IL-6 serum levels (mean values 29.9 pg/ml and 60.1 pg/ml, respectively) not correlating with Candida cell count in vaginal lavage fluid.In conclusion, serum IL-6 had strong relationship with systemic C. albicans infection while the local C. albicans infection of the vagina led to partial, prolonged and limited serum IL-6 response.

Entities:  

Keywords:  Candida albicans; interleukin-6; mouse; systemic candidiasis; vulvovaginitis

Mesh:

Substances:

Year:  2014        PMID: 24631754     DOI: 10.1556/AMicr.61.2014.1.6

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  4 in total

1.  The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.

Authors:  Aliz Bozó; Marianna Domán; László Majoros; Gábor Kardos; István Varga; Renátó Kovács
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

2.  In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis.

Authors:  Renátó Kovács; Jeanett Holzknecht; Zoltán Hargitai; Csaba Papp; Attila Farkas; Attila Borics; Lilána Tóth; Györgyi Váradi; Gábor K Tóth; Ilona Kovács; Sandrine Dubrac; László Majoros; Florentine Marx; László Galgóczy
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Diagnostic efficacy of serum cytokines and chemokines in fungal bloodstream infection in febrile patients.

Authors:  Qi Wang; Ming Yang; Chi Wang; Jiayue Cui; Xinjun Li; Chengbin Wang
Journal:  J Clin Lab Anal       Date:  2020-01-23       Impact factor: 2.352

4.  The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles-resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11.

Authors:  Wenli Feng; Jing Yang; Yan Ma; Zhiqin Xi; Xiaoqin Zhao; Xiaoxia Zhao; Min Zhao
Journal:  Immun Inflamm Dis       Date:  2021-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.